文献速递临床试验与 GCP医学教育与科研方法

在四个欧洲国家实施针对衰弱老年人尿路感染抗生素处方的定制多层面抗生素管理干预(ImpresU):一项实用整群随机对照试验的过程评价

Implementation of a tailored multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for urinary tract infections in frail older adults (ImpresU) in four European countries: a process evaluation alongside a pragmatic cluster randomized controlled trial.
PubMed 文献 · Trials · 2024-10-18

本研究为在波兰、荷兰、挪威和瑞典开展的实用整群随机对照试验(RCT)的过程评价,旨在评估多层面抗生素管理干预(ASI)的实施过程。问卷由38个参与集群的254名卫生保健专业人员完成,结果显示所有干预组件基本按计划实施并被评价为有用,教育会议聚焦区分尿路感染与无症状菌尿。作者推荐使用多层面、多学科方法,使卫生保健专业人员能够反思当前实践并据此定制本地实施。

要点

  • 决策工具和工具箱材料有助于尿路感染的决策。
  • 19个干预集群均举办了区分尿路感染与无症状菌尿的教育会议。
  • 人员变动和COVID-19大流行是重要的情境障碍。

核心结论

  • 多层面抗生素管理干预的每个组件及其实施在改善异质性老年护理环境中疑似尿路感染的抗生素处方过程中具有附加价值。
  • 作者推荐使用多层面、多学科方法,使卫生保健专业人员能够反思当前实践并据此定制本地实施。

研究设计与样本

  • 在波兰、荷兰、挪威和瑞典的全科诊所和老年护理机构开展的实用整群随机对照试验的过程评价。
  • 干预包括决策工具和工具箱,采用参与式行动研究(PAR)方法实施,包含教育和评估会议。
  • 对干预组和常规护理集群中参与机构的卫生保健专业人员发放问卷,共38个参与集群的254名卫生保健专业人员完成问卷。

主要发现

  • 所有组件基本按计划实施并被评价为有用。
  • 决策工具和工具箱材料被报告有助于尿路感染的决策。
  • 19个干预集群均举办了聚焦区分尿路感染与无症状菌尿的教育会议。
  • 19个干预集群中有17个举办了评估会议,据报告有助于提醒卫生保健专业人员实施抗生素管理干预。
  • 在两类会议中,卫生保健专业人员重视所进行的反思及由此产生的对自身行为的意识,这使他们能够探索实施障碍并定制本地实施过程以克服这些障碍。

临床怎么用

  • 作者推荐使用多层面、多学科方法,使卫生保健专业人员能够反思当前实践并据此定制本地实施。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We previously performed a pragmatic cluster randomized controlled trial (RCT) in general practices and older adult care organizations in Poland, the Netherlands, Norway, and Sweden. We found that a multifaceted antibiotic stewardship intervention (ASI) substantially reduced antibiotic use for suspected urinary tract infections (UTIs) in frail older adults compared with usual care. We aimed to evaluate the implementation process of the ASI to provide recommendations for clinical practice. METHODS: We conducted a process evaluation alongside the cluster RCT. The ASI consisted of a decision-tool and a toolbox, which were implemented using a participatory-action-research (PAR) approach with sessions for education and evaluation. We documented the implementation process of the intervention and administered a questionnaire to health care professionals (HCPs) from participating organizations in the intervention and usual care clusters. We evaluated the multiple components of the intervention and its implementation following a structured framework. RESULTS: The questionnaire was completed by 254 HCPs from the 38 participating clusters. All components were largely delivered according to plan and evaluated as useful. The decision-tool and toolbox materials were reported to facilitate decision-making on UTIs. Regarding the PAR approach, educational sessions focusing on the distinction between UTIs and asymptomatic bacteriuria were held in all 19 intervention clusters. In 17 out of these 19 clusters, evaluation sessions took place, which were reported to help remind HCPs to implement the ASI. During both sessions, HCPs valued the reflection that took place and the resulting awareness of their behavior. It allowed them to explore implementation barriers and to tailor their local implementation process to overcome these. For example, HCPs organized extra educational sessions or revised local policies to incorporate the use of the decision-tool. Various HCPs took key roles in implementation. Staff changes and the COVID-19 pandemic were important contextual barriers. CONCLUSIONS: We found each component of the multifaceted ASI and its implementation to have added value in the process to improve antibiotic prescribing for suspected UTIs in a heterogeneous older adult care setting. We recommend using a multifaceted, multidisciplinary approach that enables HCPs to reflect on their current practice and accordingly tailor local implementation. TRIAL REGISTRATION: ClinicalTrials.gov NCT03970356. Registered on May 31, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hartman EAR, Groen WG, Heltveit-Olsen SR, et al. Implementation of a tailored multifaceted antibiotic stewardship intervention to improve antibiotic prescribing for urinary tract infections in frail older adults (ImpresU) in four European countries: a process evaluation alongside a pragmatic cluster randomized controlled trial. Trials. 2024. PMID: 39425170. doi:10.1186/s13063-024-08545-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。